Currently browsing - Antimicrobial Resistance

Keynote Speakers | In The News (Sept 23)

Happy Friday! In the news this week, our top keynote speakers are writing and making headlines in respected and international media. For booking enquiries, or more about these talented thought-leaders, send us a quick email for their speaking topics, expertise and latest availability.

Here are the top stories we recommend this week:


Harper Reed advocates simplicity in information technology at Indiana University


The Herald-Times | At IT conference, PayPal software developer stresses repetition, user experience 

Latest speaking topics, fee and availability for Harper Reed


Ken Rogoff discusses the pros and cons of countries going cashless

ken-rogoff cashless society
BBC The Inquiry (podcast) | Who wins in a cashless society?

Latest speaking topics, fee and availability for Ken Rogoff


Nouriel Roubini says the markets are not in a bubble

Nouriel Roubini global economy

CNBC | Nouriel Roubini sees frothiness but not a bubble

Latest speaking topics, fee and availability for Nouriel Roubini


Jeffrey Sachs says world leaders need to ramp up investment

U.S. economist Jeffrey Sachs speaks during an interview with Reuters in Rome, Italy, March 15, 2016. Picture taken March 15, 2016. REUTERS/Max Rossi

Reuters UK | World leaders must show us the money to hit goals on poverty, inequality – U.N. adviser 

Latest speaking topics, fee and availability for Jeffrey Sachs


Jim O’Neill instrumental in shaping the global conversation over Antimicrobial Resistance


Quartz | The Goldman Sachs economist who coined the term BRIC is helping tackle the antimicrobial resistance crisis

Latest speaking topics, fee and availability for Jim O’Neill


Jean-Claude Trichet knows why the European economy is lagging behind the US


Market Watch | The ECB should not be turned into a helicopter, Trichet says in interview

Latest speaking topics, fee and availability for Jean-Clause Trichet


Joseph Stiglitz discusses his new book, The Euro

Joseph-Stiglitz EU ruling Apple
Slate | Is the Euro Killing Europe?

Latest speaking topics, fee and availability for Joseph Stiflitz















Economist Jim O’Neill presents final international recommendations to defeat superbugs

A global review on antimicrobial resistance, led by economist Lord Jim O’Neill, has set out its final recommendations, providing a comprehensive action plan for the world toJim O’Neill speaker prevent drug-resistant infections and defeat the rising threat of superbugs – estimated to save the global health bill $100tn a year by the year 2050, if the problem is left to rise unchecked.

International recommendations offered by the report are greater global awareness, the end of antibiotics use in animals – or better labelling so consumers are made aware of the risks – and dedicated funding supplied by pharmaceutical companies in developing new drugs to replace existing ones that are no longer effective. The report’s release met with strong objections claiming that it fails to show how treating such a global health problem should be collaborative and not left to pharma companies to fund and solve alone.

Lastly, it asserts that GPs need better tools to diagnose patients faster and more accurately to distinguish bacterial from viral infections, before they can prescribe antibiotics. No tests currently exist to tell if symptoms are caused by bacteria rather than a virus, often meaning that antibiotics are administered inappropriately.

Read more in an article published in The Guardian today: ‘No antibiotics without a test, says report on rising antimicrobial resistance’

Jim O’Neill urges “Current antibiotics are becoming increasingly ineffective”

Jim O'Neill speakerWriting for Project Syndicate, Jim O’Neill, Chairman of the Review on Antimicrobial Resistance (AMR), discusses the state of current antibiotics, and the G-7’s commitment to tackling AMR.

O’Neill argues that current antibiotics are becoming ineffective, especially when fighting common illnesses, as well as serious infections, and the more serious infections such as tuberculosis and malaria are now at risk again to become incurable.

It is imperative that the G-20 – and China fight for “antimicrobial resistance” (AMR) to the next level. The failure to address these issues will affect everyone, “to the extent that by 2050, ten million people could be dying as a result of AMR.”

International communities involvement is crucial for any G-7 strategy to be successful, and “that is why members of the World Health Organization have agreed to implement a “global action plan on AMR,” and have called upon the United Nations to convene a high-level meeting of political leaders in 2016.

O’Neill outlines steps for the G-7 countries to fulfill the commitments in their joint declaration. First, he believes antibiotics in animal husbandry should be reduced, and that the best way to do this is by putting pressure on major food companies. Second, medicines should only be used when they are needed, and the key to addressing this problem is, “to develop and improve access to rapid point-of-care diagnostic tools.” Finally,“improved surveillance of the spread of drug-resistant infections, particularly in developing countries, where such data is most sparse.”

“The governments have a rare opportunity to preempt a major crisis, at a fraction of the cost of responding to the crisis once it has been escalated.”

Click here to read the full article.

For more information, or to book Jim O’Neill as a speaker for your conference or event, please contact Alex Hickman at or call 0044 (0) 20 7792 8004.

Jim O’Neill argues that “Big Pharma should redirect funds allocated toward share buybacks into research”

Jim O'Neill speakerWriting for Project Syndicate, Jim O’Neill – who is currently Chairing a formal Review into antimicrobial resistance (AMR) – argues that “Big Pharma should redirect funds allocated toward share buybacks into research.”

Jim argues that if left unaddressed, the problem of AMR could be responsible by 2050 for the deaths of some ten million people a year, along with over $100 trillion in economic damage. However, provided that adequate resources are made available, he believes that there is much we can do to mitigate the threat.

One important avenue to pursue, Jim advises, is the development of new drugs. However, a common argument made by drug companies is that they “need to be guaranteed a reward if they are to invest in developing medicines that are unlikely to deliver the kind of returns that other investments may provide.” Despite this, Jim notes that there is a good reason why pharmaceutical companies should provide financing for early-stage research into solving the problem of antimicrobial resistance: enlightened self-interest.

Drawing from his years at Goldman Sachs, Jim demonstrates that “if the banking industry had shown greater leadership on issues – for example, excessive executive pay – they would have found themselves in a much more favourable environment today.” Similarly, whilst share buybacks in the pharmaceutical industry can sometimes be legitimate, on other occasions they do not seem justified – especially when considered from the standpoint of enlightened self-interest.

He goes on to show how dubious buybacks are not confined to the pharmaceutical industry, and comments that “companies’ ability to minimise their global tax burden, while boosting their earnings per share through buybacks – in some cases financed with debt – does not strike me as a stable trend.” Instead, “industry leaders should begin asking themselves how they can contribute to averting the crises of the future.”

Click here to read the full article.

For more information, or to book Jim O’Neill as a keynote speaker for your conference or event, please contact Alex Hickman at or call 0044 (0) 20 7792 8004.

Jim O’Neill, Chairman of the Review on Antimicrobial Resistance, outlines “ten ways to kill our antibiotics complacency”

Last year, British Prime Minister David Cameron asked economist Jim O’Neill to lead a review into antimicrobial resistance (AMR), which will propose global solutions to tackle this problem.

Writing in The Times, Jim warns that “public ignorance about the worldwide danger of superbugs could cost millions of lives.” Ahead of the final report, which is due in the Spring of 2016, Jim outlines ten things that need to be done:

  1. Embark on a massive global PR exercise
  2. Wash our hands more
  3. Stop using antibiotics for animal growth promoters
  4. Explore the scope for using vaccines
  5. Dramatically improve the surveillance of resistance
  6. State-of-the-art diagnostics
  7. Improve the numbers and pay of those studying AMR
  8. A global innovation fund
  9. A priority for China’s G20 leadership
  10. Let’s have some big new drugs

Click here to read the full article (paywall).

For more information, or to book Jim O’Neill as a keynote speaker for your conference or event, please contact Alex Hickman at or call 0044 (0) 20 7792 8004.

Brics banker Jim O’Neill goes to war on superbugs

Jim O’Neill speakerJim O’Neill, the former Goldman Sachs chief economist, is spearheading a mission to tackle antimicrobial resistance, or AMR. The feature of an FT article, he was recruited last year by UK prime minister David Cameron to look for ways to reverse the rising tide of drug-resistant superbugs.

Jim has recently returned from China (pictured above next to President Xi Jinping), where he spent the last week in talks aimed at mobilising Beijing’s support. He argues that “it’s a similar challenge to climate change in that it affects everyone and can only be tackled with cross-border co-operation,” expressing hope that China will make the issue a priority of its G20 presidency next year.

“The western world made a mistake by lecturing the Bric countries about climate change,” he says. “With AMR, they must take charge of the issue because it is in the developing world that the challenge of superbugs is greatest.”

Working on a pro-bono basis from an office at the Wellcome Trust medical charity in London, Jim wants to harness global support for a UN deal on AMR by autumn 2016. An international panel of experts is helping him explore potential solutions.

Click here to read the full article.

For more information, or to book Jim O’Neill as a keynote speaker for your conference or event, please contact Alex Hickman at or call 0044 (0) 20 7792 8004.

get in touch

We’re here to help.

If you can’t find the right speaker you need, or would like speaker ideas tailored to your event,

talk to us on the details below.

For UK, Europe, Middle East and other international enquiries, please contact

Raleigh Addington

+44 2072930864

For US enquiries,

please contact

Ellis Trevor

+1 646-844-8287 

For Asia enquiries

please contact

Rafe Fletcher